These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 16380409)

  • 1. Induction chemotherapy for larynx preservation: patient selection or therapeutic effect?
    Pfister DG; Ridge JA
    J Clin Oncol; 2006 Feb; 24(4):540-3. PubMed ID: 16380409
    [No Abstract]   [Full Text] [Related]  

  • 2. Larynx preservation and survival trends: should there be concern?
    Forastiere AA
    Head Neck; 2010 Jan; 32(1):14-7. PubMed ID: 19953631
    [No Abstract]   [Full Text] [Related]  

  • 3. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm.
    Urba S; Wolf G; Eisbruch A; Worden F; Lee J; Bradford C; Teknos T; Chepeha D; Prince M; Hogikyan N; Taylor J
    J Clin Oncol; 2006 Feb; 24(4):593-8. PubMed ID: 16380415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Searching for less toxic larynx preservation: a need for common definitions and metrics.
    Forastiere AA; Trotti AM
    J Natl Cancer Inst; 2009 Feb; 101(3):129-31. PubMed ID: 19176460
    [No Abstract]   [Full Text] [Related]  

  • 5. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
    Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
    Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Conservative surgery of the larynx as an alternative to total laryngectomy after neoadjuvant chemotherapy. Initial results].
    Brasnu D; Laccourreye O; Chabardes E; Bassot V; Ménard M; Laccourreye H
    Ann Otolaryngol Chir Cervicofac; 1993; 110(3):129-33. PubMed ID: 8239332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation.
    Pointreau Y; Garaud P; Chapet S; Sire C; Tuchais C; Tortochaux J; Faivre S; Guerrif S; Alfonsi M; Calais G
    J Natl Cancer Inst; 2009 Apr; 101(7):498-506. PubMed ID: 19318632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation.
    Haddad RI
    J Natl Cancer Inst; 2009 Aug; 101(16):1157-8; author reply 1158. PubMed ID: 19567423
    [No Abstract]   [Full Text] [Related]  

  • 9. Organ preservation therapy for advanced-stage laryngeal carcinoma.
    Hoffman HT; McCulloch T; Gustin D; Karnell LH
    Otolaryngol Clin North Am; 1997 Feb; 30(1):113-30. PubMed ID: 8995140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Larynx preservation.
    Lefebvre JL
    Curr Opin Oncol; 2012 May; 24(3):218-22. PubMed ID: 22450148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative assessment of the five-year results of surgical, combined, radiation and chemoradiotherapy in laryngeal cancer (T3N0M0)].
    Tkachëv SI; Matiakin EG; Liubaev VL; Boĭkov VP; Alieva SB; Aliev BM; Kondrat'eva AP; Aketova TA; Pirogova NA; Loginova IN
    Vopr Onkol; 2006; 52(4):404-7. PubMed ID: 17024811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapy.
    Rodriguez CP; Adelstein DJ; Rybicki LA; Saxton JP; Lorenz RR; Wood BG; Strome M; Esclamado RM; Lavertu P; Carroll MA
    Head Neck; 2008 Dec; 30(12):1535-42. PubMed ID: 18704968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of larynx preservation trials.
    Lefebvre JL; Bonneterre J
    Curr Opin Oncol; 1996 May; 8(3):209-14. PubMed ID: 8794149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organ preservation surgery for laryngeal cancer.
    Tufano RP; Stafford EM
    Otolaryngol Clin North Am; 2008 Aug; 41(4):741-55, vi. PubMed ID: 18570956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a new role for induction chemotherapy in the treatment of head and neck cancer?
    Forastiere AA
    J Natl Cancer Inst; 2004 Nov; 96(22):1647-9. PubMed ID: 15547172
    [No Abstract]   [Full Text] [Related]  

  • 16. Candidates for larynx preservation: the next step?
    Lefebvre JL
    Oncologist; 2010; 15 Suppl 3():30-2. PubMed ID: 21036887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes of 849 laryngeal cancers treated in the past 40 years: are we succeeding?
    Nakayama M; Okamoto M; Hayakawa K; Miyamoto S; Ishiyama H; Komori S; Okamoto T; Seino Y; Kano K; Soda I; Sekiguchi A; Kawakami S
    Jpn J Clin Oncol; 2014 Jan; 44(1):57-64. PubMed ID: 24174633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Verrucous carcinoma of the larynx. Diagnostic and therapeutic problems].
    Daoud J; Ghorbel M; Frikha M; Ben Hamed Y; Jlidi R; Walha J; Sellami M; Drira M
    Bull Cancer; 1997 Mar; 84(3):329-30. PubMed ID: 9207880
    [No Abstract]   [Full Text] [Related]  

  • 19. Commentary: phase III trial to preserve the larynx: induction chemotherapy and radiotherapy versus concurrent chemotherapy and radiotherapy versus radiotherapy--intergroup trial R91-11.
    Wolf GT
    J Clin Oncol; 2001 Sep; 19(18 Suppl):28S-31S. PubMed ID: 11560968
    [No Abstract]   [Full Text] [Related]  

  • 20. Approaches to preserve larynx function in locally advanced laryngeal and hypopharyngeal cancer.
    Rudat V; Pfreundner L; Hoppe F; Dietz A
    Onkologie; 2004 Aug; 27(4):368-75. PubMed ID: 15347892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.